loading

Finanzdaten der Profound Medical Corp-Aktie (PROF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
53.48%
2.483
5.337 5.977 5.289 2.211
Cost Of Revenue
64.39%
0.536
1.505 1.986 1.358 0.593
Gross Profit
49.19%
1.947
3.832 3.991 3.931 1.618
Operating Expenses
9.79%
13.01
11.85 11.36 12.84 15.42
Operating Income/Loss
37.96%
-11.07
-8.021 -7.369 -8.913 -13.81
Nonoperating Income/Loss
59.21%
1.581
0.993 -0.78 1.057 -1.825
Income/Loss From Continuing Operations Before Tax
34.96%
-9.485
-7.028 -8.149 -7.856 -15.63
Income Tax Expense/Benefit, Current
151.85%
0.068
0.027 0.012 0.10 0.078
Income Tax Expense/Benefit, Deferred
550.00%
-0.013
-0.002 0.014 0.021 -0.014
Income Tax Expense/Benefit
120.00%
0.055
0.025 0.026 0.121 0.064
Net Income/Loss
35.26%
-9.54
-7.053 -8.175 -7.977 -15.70
Basic Average Shares
0.15%
36.35
36.30 0.1134 30.10 30.05
Diluted Average Shares
0.15%
36.35
36.30 0.1134 30.10 30.05
Basic Earnings Per Share
236.84%
-0.26
0.19 0.27 0.26 0.52
Diluted Earnings Per Share
236.84%
-0.26
0.19 0.27 0.26 0.52
$3.63
price down icon 6.92%
$27.42
price down icon 2.18%
QSI QSI
$1.12
price down icon 14.50%
LAB LAB
$0.629
price down icon 4.47%
$2.17
price down icon 7.26%
$4.51
price down icon 3.43%
Kapitalisierung:     |  Volumen (24h):